UPDATE 1-Pharma execs weigh in on possible changes under Trump

Dec 1 (Reuters) - The top executives at two of the largest

U.S. drugmakers weighed in on Thursday for the first time on

possible changes for the industry next year under U.S.

President-elect Donald...

Read more